Healthy volunteers test two autoinjectors for drug delivery
NCT ID NCT06475729
First seen Jan 05, 2026 · Last updated May 01, 2026 · Updated 23 times
Summary
This study tested whether two different autoinjectors deliver the same amount of mirikizumab into the bloodstream. 498 healthy adults received a single injection under the skin. The goal was to see if the new 2-mL autoinjector works as well as the standard 1-mL version.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CenExel ACT
Anaheim, California, 92801, United States
-
Clinical Pharmacology of Miami
Miami, Florida, 33014-3616, United States
-
Fortrea Clinical Research Unit
Daytona Beach, Florida, 32117, United States
-
Fortrea Clinical Research Unit
Dallas, Texas, 75247, United States
-
Fortrea Clinical Research Unit
Madison, Wisconsin, 53704, United States
-
QPS Missouri
Springfield, Missouri, 65802, United States
Conditions
Explore the condition pages connected to this study.